SLC24A2 and glioblastoma: In detail, SLC24A2 was notably lower expressed in glioblastoma (GBM), kidney renal clear cell carcinoma (KIRC), and kidney renal papillary cell carcinoma (KIRP) (all P < 0.05) than in adjacent tissues (Figure 6(a)), whose lower expression significantly correlated with high survival time in KIRC (HR = 1.49, P = 0.011) and KIRP (HR = 2.05, P = 0.016) (Figure 6(b)).